The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The outcome of patients with advanced hepatocellular carcinoma (HCC) in pre- and post-sorafenib eras using the SEER database.
Jiahuai Tan
No relevant relationships to disclose
Minsig Choi
No relevant relationships to disclose
Philip Agop Philip
No relevant relationships to disclose
Gregory Dyson
No relevant relationships to disclose
Anthony Frank Shields
No relevant relationships to disclose
Richard D. Kim
No relevant relationships to disclose